Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Diabetes Care
|
February 18, 2016
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
Jennifer L Sherr, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care
|
September 24, 2016
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270
Michael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care
|
February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics
|
September 29, 2022
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
Laurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
The New England Journal of Medicine
|
August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Marc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Diabetes Care
|
December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
Lauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System
Melissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
The New England Journal of Medicine
|
September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes
, William V Tamborlane, Roy W Beck, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Diabetes Care
|
February 18, 2016
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
Jennifer L Sherr, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care
|
September 24, 2016
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270
Michael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care
|
February 18, 2017
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, et al.
Diabetes Technology & Therapeutics
|
September 29, 2022
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
Laurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
The New England Journal of Medicine
|
August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Marc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Diabetes Care
|
December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
Lauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
JAMA
|
June 2, 2021
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial
Thomas Martens, Roy W Beck, Ryan Bailey, et al.
Diabetes Care
|
September 30, 2021
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Grazia Aleppo, Roy W Beck, Ryan Bailey, et al.
Diabetes Technology & Therapeutics
|
March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System
Melissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
The New England Journal of Medicine
|
September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes
, William V Tamborlane, Roy W Beck, et al.
Page
of 15